DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The "Human Papillomavirus Associated Diseases - Pipeline Insights, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Human Papillomavirus Associated Diseases - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects.The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Human Papillomavirus Associated Diseases - Pipeline Insights, 2018 Overview

3. Pipeline Therapeutics

An Overview of Pipeline Products for Human Papillomavirus Associated Diseases - Pipeline Insights, 2018

4. Comparative Analysis

5. Products in Clinical Stage

Product DescriptionResearch and DevelopmentProduct Development Activities

6. Products in Pre-Clinical and Discovery Stage

Product DescriptionResearch and DevelopmentProduct Development Activities

7. Therapeutic Assessment

Assessment by Route of AdministrationAssessment by Stage and Route of AdministrationAssessment by Molecule TypeAssessment by Stage and Molecule Type

8. Inactive Products

Product DescriptionResearch and DevelopmentProduct Development Activities

Companies Mentioned

Lee PharmaceuticalsCEL-SCI CorporationAviragen TherapeuticsTamir Biotechnology, IncShanghai FudanZhangjiang BioPharmaceuticalRXi Pharmaceuticals, CorpNovan, IncKite Pharma, Inc.Genexine, IncAntiva BiosciencesInthera Bioscience AGUbiVac, LLCCue BiopharmaFor more information about this drug pipelines report visit https://www.researchandmarkets.com/research/kjzbsj/human?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005953/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs,Sexual and Reproductive Health Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/06/2018 05:09 PM/DISC: 09/06/2018 05:09 PM

http://www.businesswire.com/news/home/20180906005953/en